Doug has over 20 years of experience in the pharmaceutical and CRO industry, leading clinical operations, site management, and project management teams with proven success in leading proactive global innovative projects, driving change management, process improvement, program budgets and leveraging client relationships. He has played a pivotal role as the lead for GAP’s blood and digital biomarker study (Bio-Hermes 001), recruitment initiatives, optimizing clinical trials, budget implementation, and has co-authored and published abstracts including at AAIC and CTAD. Doug earned his BS, Public Health-Health Administration from Indiana University.